$4.59-0.05|(-1.08%)
52W H: 7.9752W L: 3.03Beta: 1.20

About MiMedx Group Inc

  • Industry: Biotechnology
  • Exchange: NASDAQ NMS - GLOBAL MARKET
  • Country: US
  • Website: https://mimedx.com/

Frequently Asked Questions

What is the 52-week range for MDXG?

The 52-week high is $7.97 and the 52-week low is $3.03.

What is the P/E ratio for MDXG?

The Price to Earnings (P/E) ratio is 107.24.

What is the dividend yield for MDXG?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is 2.61%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 1.76%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 3.91.

Analyst Recommendation Trends

Wall Street analyst consensus for MDXG over the last few months:

2026-09-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 9
S.Buy: 2
Hold: 1
Sell: 0

Latest MDXG News

MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter

Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological Product Order Further Holds That Minimal-Manipulation Analysis Must Consider Tissue Characteristics Relevant to Reconstruction, Repair or Replacement in the Recipient MARIETTA, Ga., Sept. 23, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that the U.S. District Court for the Northern District of Georgia issued a favorable rul

Yahoo9/23/2026

MiMedx Group Announces U.S. Court Issues Favorable Ruling In Co.'s Litigation Against FDA's Regulatory Classification Of AXIOFILL

MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced that the U.S. District Court for the Northern District of Georgia issued a favorable ruling in the Company’s litigation

Benzinga9/23/2026

MIMEDX to Participate in Upcoming Investor Conferences

MARIETTA, Ga., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Cantor Global Healthcare Conference | New York, NYWednesday, September 9, 20261:1 sessions Lake Street BIG10 Best Ideas Growth Conference | New York, NYThursday, September 10, 20261:1 sessions Investors interested in meeting with senior management at these events may contact th

Yahoo9/8/2026

Related Stocks (Peers)

Companies operating in similar sectors to MDXG:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-07-02DOUG RICE-12,749$3.95$50,359
2026-06-24Maersk-Moller Kimberly-19,820$3.83$75,911
2026-06-10Newton Todd+50,913$3.64$185,323
2026-06-10Olson Tiffany+50,913$3.64$185,323
2026-06-10PUHY DOROTHY E+50,913$3.64$185,323
2026-06-10BIERMAN JAMES L+50,913$3.64$185,323
2026-06-10HAWKINS WILLIAM A+50,913$3.64$185,323
2026-03-13Maersk-Moller Kimberly-6,762$4.38$29,618
2026-03-13Hulse William Frank IV-20,245$4.38$88,673
2026-03-10Maersk-Moller Kimberly-21,270$4.5$95,715
2026-03-10Maersk-Moller Kimberly+42,845$4.5$192,803
2026-03-10Hulse William Frank IV-61,460$4.5$276,570
2026-03-10Hulse William Frank IV+136,364$4.5$613,638
2026-03-10DOUG RICE-96,363$4.5$433,634
2026-03-10DOUG RICE+243,000$4.5$1,093,500
2026-03-04Maersk-Moller Kimberly+62,068--
2026-03-04Maersk-Moller Kimberly+74,163--
2026-03-04Whitlow Ricci S+62,068--
2026-03-04Whitlow Ricci S+74,163--
2026-03-04Hulse William Frank IV+62,758--
2026-03-04Hulse William Frank IV+74,987--
2026-03-04DOUG RICE+62,068--
2026-03-04DOUG RICE+74,163--
2026-03-04Capper Joseph H+310,574--
2026-03-04Capper Joseph H+371,094--
2026-02-13Whitlow Ricci S-61,961$5.12$317,240
2025-11-06Maersk-Moller Kimberly-58,300$7.4156$432,329